Recklessness as a hallmark of aggressive cancer (Q36921698)

17 August 2017

1 reference

title

Recklessness as a hallmark of aggressive cancer (English)

1 reference

17 August 2017

Makoto Noda

1

1 reference

PubMed ID

17725805

17 August 2017

Chiaki Takahashi

series ordinal

2

1 reference

17 August 2017

28 August 2007

1 reference

17 August 2017

1 reference

17 August 2017

98

1 reference

17 August 2017

11

1 reference

17 August 2017

1659-1665

1 reference

Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Involvement of the Sp1 site in ras-mediated downregulation of the RECK metastasis suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Oncogene-mediated downregulation of RECK, a novel transformation suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

RECKing MMP function: implications for cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Developmental biology: vasculogenesis is a wreck without RECK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Membrane-associated MMP regulators: novel cell adhesion tumor suppressor proteins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Metalloproteinase inhibitors: biological actions and therapeutic opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing--cysteine-rich protein with Kazal motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Immunohistochemical detection of MT1-MMP, RECK, and EMMPRIN in ameloblastic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

The possible mechanism of enhanced carcinogenesis induced by genotoxic carcinogens in rasH2 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Matrix metalloproteinase inhibitor RECK expression in canine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Involvement of histone deacetylation in ras-induced down-regulation of the metastasis suppressor RECK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Apicidin, an inhibitor of histone deacetylase, prevents H-ras-induced invasive phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

RECK is a target of Epstein–Barr virus latent membrane protein 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Tissue inhibitors of metalloproteinase 2 inhibits endothelial cell migration through increased expression of RECK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

TIMP-2 upregulates RECK expression via dephosphorylation of paxillin tyrosine residues 31 and 118.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

TIMP-2 promotes cell spreading and adhesion via upregulation of Rap1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

RECK-mediated suppression of tumor cell invasion is regulated by glycosylation in human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Tgat oncoprotein functions as a inhibitor of RECK by association of the unique C-terminal region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Molecular cloning of canine membrane-anchored inhibitor of matrix metalloproteinase, RECK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Expression analysis of the entire MMP and TIMP gene families during mouse tissue development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Basement membrane remodeling is essential for Drosophila disc eversion and tumor invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

The membrane-anchored MMP-regulator RECK is a target of myogenic regulatory factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Dual effects of the membrane-anchored MMP regulator RECK on chondrogenic differentiation of ATDC5 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

RECK modulates Notch signaling during cortical neurogenesis by regulating ADAM10 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) interacts with membrane type 1 matrix metalloproteinase and CD13/aminopeptidase N and modulates their endocytic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Establishment of the genomic structure and identification of thirteen single-nucleotide polymorphisms in the human RECK gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Expression and localisation of the new metalloproteinase inhibitor RECK (reversion inducing cysteine-rich protein with Kazal motifs) in inflamed synovial membranes of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Matrix metalloproteinases as modulators of inflammation and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

Suppression of matrix metalloproteinase-9 by prostaglandin E(2) in peritoneal macrophage is associated with severity of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00588.X

10.1111/J.1349-7006.2007.00588.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17725805